• Latest Posts
More News! 4 Dec 2023

FDA CAR-T cell therapy warning: Are T cells malignant?

Sponsored by 28 Nov 2023

Standardizing tissue quality: Your key to accurate early discovery insights

In Depth 23 Nov 2023

The next frontier in immunotherapy? CAR-Macrophages as a novel cancer treatment strategy

M&As: what’s up with the ADC buying spree?

Opinion 1 Nov 2023

Could this be the start of a new era for PI3K drugs?

Podcast 27 Oct 2023

Beyond Biotech podcast 69 – improving access to cell and gene therapy

Sponsored by 24 Oct 2023

Chronic inflammation and cancer: how can preclinical models revolutionize our understanding?

In Depth 18 Oct 2023

Going nuclear: radiopharmaceuticals see surge in funding

In Depth 13 Oct 2023

How close are we to a cure for metastatic breast cancer?

In Depth 12 Oct 2023

Can immunometabolism-based therapies transform the way cancers and autoimmune diseases are treated?

In Depth 6 Oct 2023

Will the U.S. Cancer Moonshot program land its target to halve cancer death rates?